Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Barbara A. Neilan"'
Autor:
Barbara A, Neilan
Publikováno v:
Postgraduate medicine. 95(1)
Preview A wide variety of medical emergencies may develop in patients with cancer. Some of the more common ones can be anticipated and prevented; others are less predictable, especially those caused by the newer chemotherapy regimens. When emergencie
Autor:
Barbara A. Neilan
Publikováno v:
The Linacre Quarterly. 80:277-281
In April 1962, Vittorio Micheli, a soldier in the Italian Army, developed rapidly increasing pain in his left buttock region. X-rays of the left hip showed osteolysis involving the ilium and the roof of the acetabulum. A biopsy of the gluteal muscle
Autor:
Robert B. Epstein, Charles A. Coltman, Walter J. Stuckey, Richard Pazdur, Paik N. Kim, Barbara A. Neilan, John Crowley, Robert M. O'Bryan
Publikováno v:
Cancer. 65:856-860
Small cell lung cancer patients who failed primary systemic therapy or who failed after response were randomly assigned to salvage treatment with etoposide (VP-16) and cisplatin (CDDP) or bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclop
Autor:
Barbara A. Neilan
Publikováno v:
Clinics in Geriatric Medicine. 3:625-635
Autor:
Glenn Mills, Charles A. Coltman, John D. Cowan, Barbara A. Neilan, Khadir Hussein, Steve Dahlberg, Conrad H. Gumbart
Publikováno v:
American Journal of Clinical Oncology. 12:507-510
Twenty-nine patients with heavily pretreated acute leukemia in relapse were treated with bisantrene (maximum dose 120 mg/m2/day x 5) in a phase II study. Twenty-seven of the 29 patients were evaluable for response, receiving a total of 53 courses of
Publikováno v:
Biochemical Medicine. 30:342-348
The methylation of erythrocyte membrane proteins has been investigated with fractionated reversible and irreversible sickle erythrocytes to better understand conflicting results obtained from two laboratories (Green and Kalra (6), Ro et al. (1). When
Autor:
Barbara A. Neilan
Publikováno v:
CA: A Cancer Journal for Clinicians. 33:237-241
Autor:
John D. Cowan, Barbara A. Neilan, Robert B. Epstein, Stephanie Green, Jerry T. Guy, David S. Alberts, William S. Fletcher, Nancy Mason-Liddil
Publikováno v:
Investigational New Drugs. 5:289-292
Patients with a pathologically proven diagnosis of malignant melanoma were entered into a phase II trial of bisantrene. Eligibility criteria included: measurable, metastatic disease; performance status 0-2 SWOG; and adriamycin total cumulative dose o
Autor:
Luigi Taddeini, Barbara A. Neilan
Publikováno v:
Journal of the American Geriatrics Society. 27:170-173
The numbers and percentages of active rosette-forming T cells were measured in two age groups, to assess the effects of aging. The study included 21 healthy persons in the 20--40 age group and 25 persons without major disease in the 60--85 age group.
Autor:
Barbara A. Neilan
Publikováno v:
Postgraduate Medicine. 68:207-212
Hematologic and immunologic changes following splenectomy for trauma include abnormal RBC morphology, leukocytosis, thrombocytosis, impaired clearance of blood-borne particulate antigens, and reduced antibody formation. These abnormalities may be the